Reply  by Li, Zhi-Yong et al.
JOURNAL OF VASCULAR SURGERY
August 2009474 Letters to the Editortechnical aspects of stent deployment in the cephalic arch could be
shared with others. We are keenly aware of the need to preserve
“venous capital” but have not found stenting of the cephalic arch
to be a factor in its diminution. This is borne out by our life-table
analysis for a 1 year functional patency of 100%.1
Stent placement in the cephalic arch, as elsewhere, is an
attempt to preserve patency of an existing access. Our study
showed that covered stents demonstrated significantly better pa-
tency than bare stents.1 The rate of restenosis requiring dilatation
in the stent graft group was half of that in the bare stent group. This
was a significant improvement but, as Dr Turmel-Rodrigues states,
redilatations are still required despite covered stent placement. In
fact, in the constellation of conserving venous capital, dilatations
and redilatations are required to keep accesses open and to increase
dialysis time for any particular access, stented or not.3
Our study clearly showed that the use of bare stents for
cephalic arch restenosis does not prevent rapid in-stent restenosis.
Stent grafts performed significantly better and are the preferred
solution for this lesion with improved patency and decrease in
re-intervention rates (Fig). It is logical to extrapolate from this
study that bare stents are not an appropriate solution for any
venous lesion in arteriovenous accesses that require stents and that
covered stents will do better. Moreover, we would encourage the
use of stent grafts that are completely covered and flexible. Need-
less to say, we think it incorrect to apply reported anecdotal
findings concerning bare stent occlusions in central veins to the
deployment of stent grafts in cephalic arch restenosis. We do not
see any reason to prohibit their use in this circumstance.
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Regarding “Impact of calcification and intraluminal
thrombus on the computed wall stresses of abdominal
aortic aneurysm”
We read with great interest the article by Li et al, concerning
the effect of intraluminal thrombus on the values of peak wall
stress, in 3D reconstructed individualized abdominal aortic aneu-
rysm (AAA) models.1 After having used the method of Finite
Element Analysis, the authors concluded that the relative amount
on thrombus reduces the maximum stress in AAA in a rather linear
way (r  0.863, P  .001). This is one of the largest series (20
patients) with a rather interesting finding, adding to the existing
information about the biomechanical influence of thrombus on
maximum stress and consequently on the risk of rupture.2
Although the amount of thrombus is sufficiently addressed,
we believe that an additional point needs to be considered, namely
the concurrent influence of the geometric modifications inside the
lumen that the existence of thrombus induces, when compared
with reconstructed AAA models without thrombus. These shiftscan be represented by the alterations in the mean curvature,
torsion, tortuosity in the lumen centerlines in each case.3
In our laboratory, we also used the Finite Element Analysis
method and confirmed the good level of correlation between the
reduction in maximum stress and the relative amount of thrombus
in a series of 19 patients (Spearman’s non parametric r  0.5, P 
.03). However, when we used a partial correlation analysis (non
parametric Spearman test), enabling us to control for the difference
in the geometry parameters that have shown to have an influence
on maximum stress magnitude,4 we failed to show any statistical
significance for the relationship between stress reduction and the
relative amount of thrombus (Spearman’s   0.413, P  .112).
This may imply that the protective role of thrombus is not only a
matter of amount, but could be influenced by the geometry of its
distribution. This observation could offer a new insight into the
limitations of the protective role of thrombus.
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We thank Dr Georgakarakos et al for the interest they have
shown in our study.1 They confirmed our finding in their study
that a good correlation existed between maximum wall stress and
the relative amount of thrombus. However, by employing partial
correlation analysis and controlling the geometric variations, they
reported that the difference between the above was not statistically
significant. This might imply that peak wall stress was affected by
the geometric variations rather than the amount of thrombus
alone.
We would like to impress on the point that although this may
be the case, the geometric variation is itself dependent on the
volume and location of the thrombus. The concentricity or eccen-
tricity of thrombus by changing the centerline curvature can alter
the peak wall stress. The location and volume of thrombus may also
affect the pattern of aneurysm expansion.2,3 There is an analogy
between the role of thrombus in altering the aneurysm wall stress
and the role of calcification in atheromatous plaques. Convention-
ally, the amount of calcification was used as an indicator of plaque
vulnerability but our group has shown that location is another key
determinant of plaque vulnerability.4 Similarly, we hypothesize
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location and impact on the geometry of the arterial lumen can
affect the wall stress and ultimately result in variable pattern of
aneurysm growth. A prospective longitudinal is therefore required
to assess the changes in thrombus volume, resultant change in
lumen curvature, and pattern of aneurysm growth/expansion,
before we can say that tortuosity of lumen centerline is the key
determinant of increasing the aneurysm wall stress.
Another important area worth exploring is the material behav-
ior of intraluminal thrombus. It is most likely a non-homogeneous
material with a complex property. A large ex vivo experiment is
needed for future study in this area to improve our understanding
of aneurysm material properties and failure strength. This can help
in creating more realistic computational models, which could be
used as a clinical adjunct in the future for effective decision making
in aneurysm repair.
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Regarding “Risk-adjusted 30-day outcomes of carotid
stenting and endarterectomy: Results from the SVS
Vascular Registry”
We have read the study by Sidawy et al1 about 30-day out-
comes of carotid artery stenting (CAS) compared with endarterec-
tomy (CEA) with great interest. Unfortunately, we are forced to
conclude that major flaws in the study prevent drawing meaningful
conclusions from this observational cohort study. Although cohort
studies can sometimes be powerful tools in assessing treatment
effectiveness,2 the authors’ study fails to meet minimal standards
for such studies; most importantly, (1) complete and unbiased
follow-up of study end points, and (2) rigorous control for con-
founders.
The validity of the conclusions drawn from a study such as
theirs, with only 44% follow-up, is extremely limited. Those lost to
follow-up are likely to be less adherent to concomitant drug
therapy and are often more likely to have had complications; or in
contrast, sometimes those who are doing extremely well may waive
follow-up visits.3-5 In general, 80% follow-up in longitudinal stud-
ies is considered a minimum, and 90% follow-up is generally
feasible in short follow-up studies like that of Sidawy et al.1 This
study’s poor follow-up is made worse by the different follow-up
rates between groups, by the reliance on self-report, and by
the presence of systematic differences between CEA and CAS
follow-up, because Centers for Medicare and Medicaid Servicesrules require in-hospital results for CAS for recertification,
whereas there is no such mandate for CEA.
Furthermore, controlling for all potential confounders is al-
ways important in cohort studies, but particularly in those in which
the choice of intervention is heavily influenced by patient factors
(ie, “selection”).2 Those who are more frail or who have higher
surgical risk are generally much more likely to have a minimally
invasive procedure (CAS) instead of a surgery (CEA), and biases
due to such patient and provider selection are notoriously difficult
to adjust for in cohort studies, usually requiring special methods
such as instrumental variable analyses.2
The results of Sidawy et al are in conflict with several random-
ized controlled trials comparing these two interventions and re-
porting equivalence of the two interventions,6-9 even in the long-
term.6 Therefore, we suggest that the short-term differences found
in this observational cohort study with poor follow-up and likely
inadequate control for confounding do not provide useful evi-
dence on this important clinical topic.
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The authors appreciate the comments from Drs Meier and
Hayward indicating potential flaws in our article, the first being
lack of complete and unbiased follow-up and the second being
inability for rigorous control for confounders. These weaknesses
were already identified as issues inherent to a study based on
